We are a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system. Our shares are listed on the SIX Swiss Exchange (NWRN).
May 7, 2019 - Congress Center, Basel, Switzerland
April 16-17, 2019 - Amsterdam, The Netherlands
April 7-9, 2019 - Grosvenor House, London, UK